Drug class
Mitochondrial enzyme cofactor; antioxidant and redox-modulating agent
Mechanism of action
Alpha-lipoic acid is a cofactor for mitochondrial dehydrogenase complexes and can be reduced to dihydrolipoic acid, which participates in redox reactions and antioxidant recycling. It can scavenge reactive oxygen species and influence cellular redox signalling.
General use cases
- Used in some countries for symptomatic treatment of diabetic peripheral neuropathy, including oral and intravenous formulations; indications and authorisation vary by jurisdiction.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
